基于对比增强乳腺X线摄影的影像组学-临床模型用于乳腺活检结局预测
该单机构研究纳入BI-RADS 4A/4B/4C或5类病灶且活检前接受对比增强乳腺X线摄影的女性,用影像组学特征和4项放射科医生评估的描述符构建逻辑回归模型预测活检结局。201例用于模型开发/训练,86例作为内部测试集,影像组学模型AUC为0.90,临床描述符模型AUC为0.81,两者联合AUC为0.88;在初始BI-RADS 4A或4B患者中,联合模型使PPV3从放射科医生的6%提高到18%(4A)及从17%提高到25%(4B)。
要点
- 对比增强乳腺X线摄影影像组学联合临床描述符模型预测活检结局的AUC为0.88。
- 在初始BI-RADS 4A患者中,联合模型使PPV3从放射科医生的6%提高到18%。
- 在初始BI-RADS 4B患者中,联合模型使PPV3从放射科医生的17%提高到25%。
核心结论
- 基于对比增强乳腺X线摄影的影像组学特征与临床描述符联合的机器学习模型可预测BI-RADS 4A/4B/4C或5类病灶女性的乳腺活检结局。
研究设计与样本
- 符合HIPAA、经IRB批准的单机构研究,纳入活检前接受对比增强乳腺X线摄影且病灶为BI-RADS 4A/4B/4C或5类的女性;201例用于模型开发/训练,86例作为独立内部测试集;采用逻辑回归模型,输入为影像组学特征和4项放射科医生评估的定性描述符;以AUC衡量模型性能,并在BI-RADS 4A或4B病灶亚组中评估阳性预测值(PPV)。
诊断标准与关键数值
- 影像组学模型预测活检结局的AUC为0.90。
- 临床描述符模型预测活检结局的AUC为0.81。
- 影像组学与临床描述符联合模型预测活检结局的AUC为0.88。
- 在初始BI-RADS 4A患者中,联合模型使PPV3从放射科医生的6%提高到18%。
- 在初始BI-RADS 4B患者中,联合模型使PPV3从放射科医生的17%提高到25%。
临床应用与阅片要点
- 对BI-RADS 4A/4B/4C或5类病灶,可基于活检前对比增强乳腺X线摄影的影像组学特征联合4项放射科医生定性描述符构建模型预测活检结局。
- 在初始BI-RADS 4A患者中,联合模型报告的PPV3为18%,高于放射科医生的6%。
- 在初始BI-RADS 4B患者中,联合模型报告的PPV3为25%,高于放射科医生的17%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: In the USA over 1 million breast biopsies are performed annually. Approximately 9.6% diagnostic exams were given Breast Imaging Reporting and Data System (BI-RADS) ≥4A, most of which are 4A/4B. Contrast-enhanced mammography (CEM) may improve biopsy outcome prediction for this subpopulation, but machine learning-based analysis of CEM is largely unexplored. We aim to develop a machine learning-based analysis of CEM using computer-extracted radiomics and radiologist-assessed descriptors to predict breast biopsy outcomes of BI-RADS 4A/4B/4C or 5 lesions.
MATERIALS AND METHODS: This HIPPA-compliant, IRB-approved study included women in a single institution who had BI-RADS 4A/4B/4C or 5 lesions and underwent CEM imaging prior to biopsy. Logistic regression models were built to predict biopsy outcomes using radiomics features and four radiologist-assessed qualitative descriptors. A cohort of 201 patients was used for model development/training, and an independent group of 86 patients were used as an internal test set. AUC was used to measure model's performance. Positive predictive value (PPV) was assessed on subgroups of BI-RADS 4A or 4B lesions.
RESULTS: Model AUC was 0.90 for radiomics, 0.81 for clinical descriptors and 0.88 for their combination. On patients with an initial BI-RADS 4A or 4B scores, model combining radiomics and clinical descriptors of pre-biopsy CEM increased PPV3 to 18% from the radiologist's 6% for 4A patients, and to 25% from the radiologist's 17% for 4B patients.
CONCLUSION: Machine learning models combining radiomics features and clinical descriptors on CEM can predict breast biopsy outcomes on women with BI-RADS 4A/4B/4C or 5 lesions.
引用
- Liu C, Patel P, Arefan D, et al. A Radiomic-Clinical Model of Contrast-Enhanced Mammography for Breast Cancer Biopsy Outcome Prediction. Acad Radiol. 2025. PMID: 39799013. doi:10.1016/j.acra.2024.12.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。